Largest publicly shared gift for liver research in U.S. history to transform liver care at VCU – VCU News

Share Article

One VCU: Better Together – return to campus updates and resources. Read more
Feb. 15, 2022
By Tom Gresham
Virginia Commonwealth University will radically expand treatment options for liver and liver-related metabolic diseases thanks to a historic, transformational $104 million gift from R. Todd Stravitz, M.D., and his family’s Barbara Brunckhorst Foundation.
This gift is the largest in VCU’s history, the second-largest publicly shared gift to a university in Virginia and the largest publicly shared gift to support liver research in U.S. history — over four times more than the previous largest gift. It will position VCU as a global leader in liver disease and metabolic health research, teaching and patient care.
“Words cannot capture my feelings of gratitude for the transformative gift of Dr. Todd Stravitz and the Barbara Brunckhorst Foundation,” said Michael Rao, Ph.D., president of VCU and VCU Health. “Todd has made history with his incredible leadership and generosity to VCU, supporting an institute that will forever change VCU and catalyze its commitment to our work with the human liver and metabolism. This gift firmly puts the needs of patients first.”
Rao continued: “The institute’s research will have an enormous impact on our lives, changing medicine and our understanding of the role the liver plays in human health. This gift is extraordinarily generous, and it is most certainly generative. It allows us to bring together top teams to deliver clinical care, to ask important questions, develop new tools to explore what causes liver disease and how we stop it, prevent it and even reverse it. Most importantly, it will immediately make a difference in the lives of thousands of people with liver disease. Ultimately, this will positively impact millions.”
Stravitz, a physician-philanthropist in the Department of Internal Medicine at VCU School of Medicine, dedicated his whole career as a liver clinician and researcher to VCU. Before retiring in 2020, he served as medical director of liver transplantation at VCU Health’s Hume-Lee Transplant Center for a decade.
About 1 in 10 Americans have some type of liver disease, and it is one of the top 10 factors reducing life expectancy in the U.S. It is sometimes called a “silent killer” because it can go unnoticed until a liver transplant is the only treatment option. In 2021, about three people died on the liver transplant waiting list every day.
“The vision for this institute is to make liver transplant the last, but not the only, option for patients,” Stravitz said. “We will do this by investing in gene therapy and working hand in hand with biotech companies. In the process, VCU will train and educate the next generation of world-renowned liver experts.”
The Stravitz-Sanyal Institute for Liver Disease and Metabolic Health at VCU will take full advantage of VCU’s position as one of the nation’s top public research universities and its 50-year legacy of excellence in liver care and research.
The patient-centered institute will bring together and align the work of several entities already dealing with liver disease or its effects on other organs. These include the hepatology and research teams in VCU School of Medicine’s Department of Internal Medicine, VCU Health’s Hume-Lee Transplant Center, VCU Massey Cancer Center and VCU Health’s Pauley Heart Center. Over time, VCU Health will be able to serve twice the patient volume for liver-related illnesses.
Focused on translational science, the institute will grow research and health care teams for liver-related clinical specialties, such as nonalcoholic fatty liver disease, end-stage liver disease, liver transplantation, liver cancer, women’s liver health issues and rare diseases in hepatology. Arun J. Sanyal, M.D., professor in VCU School of Medicine’s Department of Internal Medicine and a researcher and liver disease specialist at VCU Health, will serve as the institute’s director.
“The liver impacts the health of all other organs because of its central role in metabolism and how the body uses energy. When the liver shuts down, all organs suffer,” said Sanyal, interim chair of the Division of Gastroenterology, Hepatology and Nutrition at VCU School of Medicine. “Discoveries of the institute will develop new diagnostics and treatments and inform practice guidelines for liver-related diseases around the world, as well as heart disease, cancer, diabetes, Alzheimer’s and kidney failure. The status quo of how we treat liver disease is no longer acceptable.”
Stravitz’s historic gift enables VCU to accelerate implementing several priorities of the new institute, which was publicly launched in December:
The remarkable private gift comes at a time when VCU’s sponsored research is also breaking records, reaching an all-time high of $363 million in 2021 — a 25% increase over the previous three years. The National Science Foundation in December ranked VCU No. 58 of public universities nationwide for federally funded research expenditures, putting the university within reach of its goal to break into the top 50 of its peers.
Sanyal’s research interests include all aspects of nonalcoholic fatty liver disease, especially nonalcoholic steatohepatitis, as well as alcohol-related liver disease and end-stage liver disease, for which he has been continuously funded by the National Institutes of Health since 1995. He oversees multiple pivotal global clinical trials and works closely with the Food and Drug Administration on the Liver Forum to accelerate diagnostics and drug development for liver disease. He has also previously served as president of the American Association for the Study of Liver Diseases.
“It takes many leaders to enact an ambitious vision like this. At VCU, we have a community of bold and visionary leaders who are extending the human experience to new levels,” Rao said. One of the early champions for the institute was Peter Buckley, M.D., former dean of VCU’s School of Medicine. The institute will operate under the umbrella of the medical school.
“We are on the cusp of changing medicine, but it takes a visionary and mentor like Arun Sanyal to train the next generation of liver specialists and make VCU the No. 1 liver center in the world,” Stravitz said. “This gift is just a means to achieve our goal to better care for patients around the world. A future where patients can undergo gene therapy to repair faulty genes instead of needing a liver transplant would be a monumental win for human health.” 
Sanyal holds the Z. Reno Vlahcevic Research Professorship in Gastroenterology, which honors his mentor, who died in 2000. A researcher at VCU Massey Cancer Center, Sanyal is also the associate director of the KL2 program for training faculty in research at VCU’s C. Kenneth and Dianne Wright Center for Clinical and Translational Research, which oversees clinical trials at the university with the help of a $21.5 million NIH grant.
“As a world-class researcher himself, Todd Stravitz exemplifies the power of medical research to make the world a better place,” Sanyal said about his longtime colleague. “With his generous, future-focused gift, Todd is ensuring that VCU’s capacity to attract outstanding minds and produce future scientific leaders is very strong for generations to come.”
The gift also establishes two endowed chairs at VCU’s School of Medicine: the Arun J. Sanyal Endowed Professor of Medicine and the Phillip B. Hylemon Endowed Professor of Medicine and Microbiology.
“This is truly a transformative moment in VCU’s history as a national research university and medical center,” said H. Benson Dendy III, rector of the VCU Board of Visitors. “On behalf of the Board of Visitors, I am tremendously grateful for this historic gift. This generous investment in VCU will accelerate the university’s efforts to prevent liver disease and to treat and heal those affected by it. The impact of this gift will be felt by people around the world.”
The institute’s official name is pending approval by VCU’s Board of Visitors.
Transcript for liver disease infographic: Liver disease: It’s more common than you thought. One billion people worldwide have some form of liver disease. It cuts across the full spectrum of society. A leading factor for the decline in life expectancy in the U.S. Liver problems are linked to heart disease, cancer, diabetes, kidney failure and Alzheimer’s. Liver transplants are lifesaving, but in short supply. Three people die on the liver transplant waiting list every day. Stravitz-Sanyal Institute for Liver Disease and Metabolic Health.
Transcript for gift impact infographic: One moment that transforms one billion lives. The impact starts here: $104 million gift to fund the new Stravitz-Sanyal Institute for Liver Disease and Metabolic Health. Training the next generation of liver experts. Finding alternatives to liver transplants. Investing in gene therapy research. Doubling our capacity for care. Creating new diagnostics and treatments. Stravitz-Sanyal Institute for Liver Disease and Metabolic Health.
Subscribe to VCU News at and receive a selection of stories, videos, photos, news clips and event listings in your inbox.
‘Transformative innovation’: VCU President Michael Rao delivers 2022 State of the University Address
Arun Sanyal is determined to transform the lives of people with liver disease around the world
The donor behind the gift that will transform liver care at VCU
Feb. 15, 2022
The donor behind the gift that will transform liver care at VCU
Feb. 15, 2022
Largest publicly shared gift for liver research in U.S. history to transform liver care at VCU
Feb. 15, 2022
Arun Sanyal is determined to transform the lives of people with liver disease around the world
Feb. 14, 2022
VCU President Michael Rao will make historic announcement at his State of the University Address
Feb. 18, 2022
Just checking in: VCU Police increase building visits as work habits change
Feb. 18, 2022
NBC News, MSNBC share story of VCU Health, Hume-Lee Transplant Center liver disease survivor
Feb. 18, 2022
Out of this world research: VCU engineering researcher sends experiments to International Space Station
Feb. 18, 2022
Social Work dean accepts position at the University of Michigan
Keep up with the latest at VCU


You might also like

Surviving 2nd wave of corona

Surviving The 2nd Wave of Corona

‘This too shall pass away’ this famous Persian adage seems to be defeating us again and again in the case of COVID-19. Despite every effort